Figure 2From: Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modellingPredicted parasite positivity at Day 3 and 42 in a global population of 10,000 individuals dosed by weight with dihydroartemisinin-piperaquine (DHA-PPQ). Panels show predicted parasite positivity for DHA and PPQ at Day 3 ((A) and (B), respectively) and at Day 42 ((C) and (D), respectively). Left of panels: Total numbers of individuals per mg/kg dosing band (white) and individuals that were parasiaemic (i e, parasite number > 108) (red). Right of panels: Numbers expressed as a percentage.Back to article page